塔奎妥单抗
Anti-Human CD3xGPRC5D Bispecific Antibody ( Talquetamab; JNJ-64407564; JNJ-7564)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Anti-Human CD3xGPRC5D Bispecific Antibody ( Talquetamab; JNJ-64407564; JNJ-7564)
CAS2226212-40-2
Storage condition store at -20°C | Avoid repeated freeze-thaw.
Security information
Product details

Talquetamab is a first-in-class bispecific antibody targeting GPRC5D and CD3, designed to recruit and activate T cells to eliminate GPRC5D-positive multiple myeloma cells. Talquetamab (JNJ-64407564) has antitumor activity.

Related
Sorry, no related items
History
Navitoclax (ABT-263)
A-1155463
Anti-Human CD3xGPRC5D Bispecific Antibody ( Talquetamab; JNJ-64407564; JNJ-7564)
TW-37
BIO (GSK-3 Inhibitor IX | 6-bromoindirubin-3-oxime | 6-Bromoindirubin-3'-oxime | MLS 2052 | (2'Z,3'E)-6-Bromoindirubin-3'-oxime | 6-BIO | 6BIO
Efungumab
Ontuxizumab (Anti-TEM1 / Endosialin / CD248)